Novadip Biosciences Raises, 10.4M for Pivotal Trial, Unlocking EIB Funds

Novadip Biosciences, a late-stage clinical biotechnology company specializing in regenerative medicine, has successfully closed a, 10.4 million (approximately $12 million) convertible financing round. The investment was spearheaded by US-based New Science…